标题
Escherichia coli-derived virus-like particles in vaccine development
作者
关键词
-
出版物
npj Vaccines
Volume 2, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-02-09
DOI
10.1038/s41541-017-0006-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Optimization and validation of ELISA immunoassay for the evaluation of in-vitro relative potency of a four-component human papillomavirus vaccine products
- (2016) Moushira M. Mostafa et al. BIOLOGICALS
- Improving global vaccine accessibility
- (2016) Andrew B Hill et al. CURRENT OPINION IN BIOTECHNOLOGY
- Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage forms
- (2016) John M. Hickey et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Detection of subtle differences in analogous viral capsid proteins by allowing unrestricted specific interaction in solution competition ELISA
- (2016) Lu Cao et al. JOURNAL OF VIROLOGICAL METHODS
- Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli
- (2016) Fabián Rueda et al. Microbial Cell Factories
- Recombinant pharmaceuticals from microbial cells: a 2015 update
- (2016) Laura Sanchez-Garcia et al. Microbial Cell Factories
- The true story and advantages of the famous Hepatitis B virus core particles: Outlook 2016
- (2016) P. Pumpens et al. MOLECULAR BIOLOGY
- Therapeutic strategies for Alzheimer's disease in clinical trials
- (2016) Justyna Godyń et al. Pharmacological Reports
- The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction
- (2016) Zhihai Li et al. STRUCTURE
- Manufacturing costs of HPV vaccines for developing countries
- (2016) Chaevia Clendinen et al. VACCINE
- Real-time stability of a hepatitis E vaccine (Hecolin®) demonstrated with potency assays and multifaceted physicochemical methods
- (2016) Xiao Zhang et al. VACCINE
- Protective Immunity Against Homologous and Heterologous Influenza Virus Lethal Challenge by Immunization with New Recombinant Chimeric HA2-M2e Fusion Protein in BALB/C Mice
- (2016) Ali Ameghi et al. VIRAL IMMUNOLOGY
- Engineering virus-like particles as vaccine platforms
- (2016) Kathryn M Frietze et al. Current Opinion in Virology
- Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
- (2016) Karl D. Brune et al. Scientific Reports
- Formulation and stabilization of recombinant protein based virus-like particle vaccines
- (2015) Nishant K. Jain et al. ADVANCED DRUG DELIVERY REVIEWS
- Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems
- (2015) Zeinab Shirbaghaee et al. BIOPOLYMERS
- FDA approves Gardasil 9 for more types of HPV
- (2015) Carrie Printz CANCER
- Enveloped virus-like particle platforms: vaccines of the future?
- (2015) Fabien Pitoiset et al. Expert Review of Vaccines
- Next generation prophylactic human papillomavirus vaccines
- (2015) John T Schiller et al. LANCET ONCOLOGY
- Long-Term Efficacy of a Hepatitis E Vaccine
- (2015) Jun Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls
- (2015) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
- (2015) Susan Thrane et al. PLoS One
- Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial
- (2015) Ting Wu et al. VACCINE
- Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
- (2015) Martin R Farlow et al. Alzheimers Research & Therapy
- Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins
- (2015) Xiao Zhang et al. Human Vaccines & Immunotherapeutics
- Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment
- (2015) Yue Zhang et al. Human Vaccines & Immunotherapeutics
- The development of a recombinant hepatitis E vaccine HEV 239
- (2015) Shao-Wei Li et al. Human Vaccines & Immunotherapeutics
- Development of Neutralizing Monoclonal Antibodies for Oncogenic Human Papillomavirus Types 31, 33, 45, 52, and 58
- (2014) Martha J. Brown et al. Clinical and Vaccine Immunology
- Prophylactic papillomavirus vaccines
- (2014) Lis Ribeiro-Müller et al. CLINICS IN DERMATOLOGY
- Biopharmaceutical benchmarks 2014
- (2014) Gary Walsh NATURE BIOTECHNOLOGY
- Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: Extending the potential of broadly cross-protecting epitopes
- (2014) Nani Wibowo et al. VACCINE
- Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin®
- (2014) Xiao Zhang et al. VACCINE
- Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers
- (2014) Jenny G.H. Low et al. VACCINE
- Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes
- (2014) Minxi Wei et al. VACCINE
- Toward the development of monoclonal antibody-based assays to probe virion-like epitopes in hepatitis B vaccine antigen
- (2014) Yibin Zhu et al. Human Vaccines & Immunotherapeutics
- Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination
- (2014) Hui Zhao et al. Human Vaccines & Immunotherapeutics
- Bioengineering virus-like particles as vaccines
- (2013) Linda H.L. Lua et al. BIOTECHNOLOGY AND BIOENGINEERING
- Hepatitis E virus: the current scenario
- (2013) Subrat Kumar et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies
- (2013) Christoph Spiess et al. NATURE BIOTECHNOLOGY
- Virus-like particle-based human vaccines: quality assessment based on structural and functional properties
- (2013) Qinjian Zhao et al. TRENDS IN BIOTECHNOLOGY
- Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy
- (2013) Qinjian Zhao et al. Human Vaccines & Immunotherapeutics
- Safety of anEscherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine
- (2013) Yuemei Hu et al. Human Vaccines & Immunotherapeutics
- Analysis of the landscape of biologically-derived pharmaceuticals in Europe: Dominant production systems, molecule types on the rise and approval trends
- (2012) Sarantos Kyriakopoulos et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
- (2012) Bengt Winblad et al. LANCET NEUROLOGY
- Construction and Characterization of Virus-Like Particles: A Review
- (2012) Andris Zeltins MOLECULAR BIOTECHNOLOGY
- First HEV vaccine approved
- (2012) Allison Proffitt NATURE BIOTECHNOLOGY
- Toolbox for Non-Intrusive Structural and Functional Analysis of Recombinant VLP Based Vaccines: A Case Study with Hepatitis B Vaccine
- (2012) Anke M. Mulder et al. PLoS One
- Hepatitis E virus capsid protein assembles in 4Murea in the presence of salts
- (2012) Chunyan Yang et al. PROTEIN SCIENCE
- Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity
- (2012) Jun Zhang et al. REVIEWS IN MEDICAL VIROLOGY
- Upgrading Public Health Programs for Human Papillomavirus Prevention and Control is Possible in Low- and Middle-income Countries
- (2012) Marc Steben et al. VACCINE
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Virus-like particles: The new frontier of vaccines for animal viral infections
- (2012) Elisa Crisci et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity
- (2012) Qinjian Zhao et al. Virology Journal
- Real time monitoring of antigenicity development of HBsAg virus-like particles (VLPs) during heat- and redox-treatment
- (2011) Qinjian Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- European Vaccine Initiative: lessons from developing malaria vaccines
- (2011) Mark J Geels et al. Expert Review of Vaccines
- Biophysical Characterization and Conformational Stability of Ebola and Marburg Virus-Like Particles
- (2011) Lei Hu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Hepatitis E vaccination—is HEV 239 the breakthrough?
- (2011) Heiner Wedemeyer et al. Nature Reviews Gastroenterology & Hepatology
- A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
- (2011) Anton P.J. Middelberg et al. VACCINE
- Virus-like particles in vaccine development
- (2010) António Roldão et al. Expert Review of Vaccines
- Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine
- (2010) Michel Deschuyteneer et al. Human vaccines & immunotherapeutics
- Microbial production of virus-like particle vaccine protein at gram-per-litre levels
- (2010) Mervyn W.O. Liew et al. JOURNAL OF BIOTECHNOLOGY
- Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial
- (2010) Feng-Cai Zhu et al. LANCET
- Hepatitis B vaccines: Protective efficacy and therapeutic potential
- (2010) M.-L. Michel et al. PATHOLOGIE BIOLOGIE
- Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris
- (2010) Janis Freivalds et al. PROTEIN EXPRESSION AND PURIFICATION
- Principles of vaccine design—Lessons from nature
- (2010) Fred Zepp VACCINE
- The Effect of the Parenteral Route of Administration on the Immune Response to Simultaneous Nasal and Parenteral Immunizations Using a New HBV Therapeutic Vaccine Candidate
- (2010) Yadira Lobaina et al. VIRAL IMMUNOLOGY
- A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
- (2010) Gunther Spohn et al. Virology Journal
- M2e-based universal influenza A vaccine
- (2009) Walter Fiers et al. VACCINE
- Quantitative characterization of virus-like particles by asymmetrical flow field flow fractionation, electrospray differential mobility analysis, and transmission electron microscopy
- (2008) Leonard F. Pease et al. BIOTECHNOLOGY AND BIOENGINEERING
- A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial
- (2008) Jacques Cornuz et al. PLoS One
- Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement
- (2008) Jon Kim Andrus et al. VACCINE
- Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies
- (2008) Marina De Filette et al. VACCINE
- Quantitative analysis of virus-like particle size and distribution by field-flow fractionation
- (2007) Yap P. Chuan et al. BIOTECHNOLOGY AND BIOENGINEERING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now